KR100589483B1 - 아목시실린 및 클라불란산 또는 그의 염의 혼합물 함유분산정제 및 그의 제조방법 - Google Patents
아목시실린 및 클라불란산 또는 그의 염의 혼합물 함유분산정제 및 그의 제조방법 Download PDFInfo
- Publication number
- KR100589483B1 KR100589483B1 KR1020050107745A KR20050107745A KR100589483B1 KR 100589483 B1 KR100589483 B1 KR 100589483B1 KR 1020050107745 A KR1020050107745 A KR 1020050107745A KR 20050107745 A KR20050107745 A KR 20050107745A KR 100589483 B1 KR100589483 B1 KR 100589483B1
- Authority
- KR
- South Korea
- Prior art keywords
- granules
- amoxicillin
- weight
- clavulanic acid
- microcrystalline cellulose
- Prior art date
Links
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1605—Excipients; Inactive ingredients
- A61K9/1629—Organic macromolecular compounds
- A61K9/1652—Polysaccharides, e.g. alginate, cellulose derivatives; Cyclodextrin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/425—Thiazoles
- A61K31/429—Thiazoles condensed with heterocyclic ring systems
- A61K31/43—Compounds containing 4-thia-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula, e.g. penicillins, penems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1682—Processes
Landscapes
- Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Life Sciences & Earth Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Nutrition Science (AREA)
- Physiology (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
Description
Claims (2)
- 약리활성물질로서 아목시실린 및 클라불란산 또는 그의 염의 혼합물, 붕해제, 활택제 및 부형제를 포함하며, 로울러 압축에 의해 제조되는 건식과립;상기 과립 외에는 붕해제, 활택제 및 부형제를 포함하여 제조되는 아목시실린 및 클라불란산 또는 그의 염의 혼합물의 경구용 분산정제에 있어서,상기 과립 내에는 과립 총중량의 0.5 내지 1.5중량% 활택제 및 과립 총 중량의 5 내지 15중량%의 미결정셀룰로오스를 함유하며, 과립 외에는 정제 총 중량의 20 내지 40중량%의 미결정셀룰로오스를 함유함을 특징으로 하는 경구용 분산정제.
- (A) 과립 내에는 약리활성물질로서 아목시실린 및 클라불란산 또는 그의 염의 혼합물, 붕해제, 과립 총중량의 0.5 내지 1.5중량%의 활택제 및 과립 총 중량에 대하여 5 내지 15중량%의 미결정셀룰로오스를 포함하여 로울러 압축으로 건식 과립화하는 단계; 및(B) 과립 외에는 붕해제, 활택제 및 정제 총 중량에 대하여 20 내지 40중량% 의 미결정셀룰로오스를 포함하여 단계(A)에서 얻은 건식과립과 혼합 타정함을 특징으로 하는 아목시실린 및 클라불란산 또는 그의 염의 혼합물의 경구용 분산정제의 제조방법.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1020050107745A KR100589483B1 (ko) | 2005-11-10 | 2005-11-10 | 아목시실린 및 클라불란산 또는 그의 염의 혼합물 함유분산정제 및 그의 제조방법 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1020050107745A KR100589483B1 (ko) | 2005-11-10 | 2005-11-10 | 아목시실린 및 클라불란산 또는 그의 염의 혼합물 함유분산정제 및 그의 제조방법 |
Publications (1)
Publication Number | Publication Date |
---|---|
KR100589483B1 true KR100589483B1 (ko) | 2006-06-14 |
Family
ID=37182692
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
KR1020050107745A KR100589483B1 (ko) | 2005-11-10 | 2005-11-10 | 아목시실린 및 클라불란산 또는 그의 염의 혼합물 함유분산정제 및 그의 제조방법 |
Country Status (1)
Country | Link |
---|---|
KR (1) | KR100589483B1 (ko) |
Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR20050002738A (ko) * | 2004-05-31 | 2005-01-10 | 삼아약품 주식회사 | β-락탐계 항생제 현탁정 및 그의 제조방법 |
-
2005
- 2005-11-10 KR KR1020050107745A patent/KR100589483B1/ko active IP Right Grant
Patent Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR20050002738A (ko) * | 2004-05-31 | 2005-01-10 | 삼아약품 주식회사 | β-락탐계 항생제 현탁정 및 그의 제조방법 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CA2301185C (en) | Pharmaceutical preparation comprising clodronate as active ingredient and silicified microcrystalline cellulose as excipient | |
EP2777696B1 (en) | Preparation of stable pharmaceutical dosage forms | |
US20100016322A1 (en) | Water Dispersible Pharmaceutical Formulation and Process for Preparing The Same | |
NZ505302A (en) | Flash-melt dose comprising medicament, superdisintegrant, dispersing agent, distributing agent and binder | |
BRPI0613611A2 (pt) | formulações de alta concentração de fármaco e formas de dosagens | |
WO2007058397A1 (en) | A dispersible tablet comprising the mixture of amoxicillin and clavulanic acid or its salts and processes for preparing the same | |
US8951504B2 (en) | (trimethoxyphenylamino) pyrimidinyl formulations | |
WO2005089720A1 (en) | Valsartan tablets and the process for the preparation thereof | |
WO2017217491A1 (ja) | 口腔内崩壊錠 | |
KR20160002177A (ko) | 오셀타미비어 유리염기를 포함하는 약학 조성물 | |
CN106456640B (zh) | 色瑞替尼制剂 | |
US20030211150A1 (en) | Immediate release tablet containing naproxen sodium | |
KR100589483B1 (ko) | 아목시실린 및 클라불란산 또는 그의 염의 혼합물 함유분산정제 및 그의 제조방법 | |
TWI651085B (zh) | N-[5-[2-(3,5-二甲氧基苯基)乙基]-2h-吡唑-3-基]-4-[(3r,5s)-3,5-二甲基哌-1-基]苯甲醯胺之醫藥調配物 | |
JP2000516601A (ja) | 水溶性化合物及びセルロースを含有する粒状物 | |
JP2004352633A (ja) | 酸化マグネシウム錠剤 | |
KR20060058415A (ko) | 아목시실린 및 클라불란산 또는 그의 염의 혼합물 함유조성물 및 그의 제조방법 | |
KR20200015758A (ko) | 제약 조성물 | |
KR20160140567A (ko) | 오셀타미비어 유리염기를 포함하는 약학 조성물 | |
AU2022342749A1 (en) | Pharmaceutical composition of bempedoic acid | |
WO2021099531A1 (en) | Zonisamide orodispersible tablets | |
JP2021167306A (ja) | 崩壊性粒子の製造方法 | |
RAJANI et al. | FORMULATION DEVELOPMENT AND INVITRO EVALUATION OF ROSUVASTATIN POROUS TABLETS BY USING SUBLIMATING TECHNIQUE | |
Mohammed | Preparation Method and in Vitro Evaluation Method of Rosuvastatin Porous Tablets | |
MXPA00002290A (en) | Pharmaceutical preparation comprising clodronate as active ingredient and silicified microcrystalline cellulose as excipient |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A201 | Request for examination | ||
A302 | Request for accelerated examination | ||
E701 | Decision to grant or registration of patent right | ||
GRNT | Written decision to grant | ||
FPAY | Annual fee payment |
Payment date: 20130605 Year of fee payment: 8 |
|
FPAY | Annual fee payment |
Payment date: 20140605 Year of fee payment: 9 |
|
FPAY | Annual fee payment |
Payment date: 20150608 Year of fee payment: 10 |
|
FPAY | Annual fee payment |
Payment date: 20160803 Year of fee payment: 11 |
|
FPAY | Annual fee payment |
Payment date: 20170607 Year of fee payment: 12 |
|
FPAY | Annual fee payment |
Payment date: 20180607 Year of fee payment: 13 |
|
FPAY | Annual fee payment |
Payment date: 20190605 Year of fee payment: 14 |